Results of the development of the hepatitis C prevention and control system in Kalasin Provincial Prison

Authors

  • Pissamai Surakan Office of Disease Prevention and Control 7 Khon Kaen
  • Nuttaporn Leenwiphat Office of Disease Prevention and Control 7 Khon Kaen
  • Piyathida Phutachai Office of Disease Prevention and Control 7 Khon Kaen
  • Kochtamon Uthruk Kalasin Provincial Prison
  • Panjarat Paladchai Kalasin Provincial Prison

DOI:

https://doi.org/10.14456/taj.2023.12

Keywords:

prisons, hepatitis C virus, prevention and control

Abstract

This research study utilized the concepts of Kemmis and McTaggart with the objectives of developing a model for the prevention and control of the Hepatitis C virus (HCV) in Kalasin Provincial Prison, as well as providing treatment for incarcerated individuals who are infected.  The study was conducted from October 2020 to September 2021 and was divided into three phases. Phase 1 involved analyzing the situation, identifying problems, obstacles, and related networks. Phase 2, the implementation phase, consisted of four steps (PAOR): planning, acting, observing, and reflecting. Phase 3 was the conclusion and evaluation of results. Data was collected from the analysis and summary of meetings with a network that included the Disease Control Office Region 7, Kalasin provincial prison, Kalasin Hospital, and the Kalasin Provincial Public Health Office. The study results identified the following HCV prevention and control system: (1) initial screening of inmates using a risk assessment form and blood tests; (2) prevention and control of infection spread, including educating all inmates, isolating infected inmates, and separating personal belongings; (3) treatment of HCV-infected inmates and prevention of re-infection; and (4) post-release care, follow-up, and treatment continuation. From the implementation, 3,328 inmates (100%) were screened, 343 (10.3%) were found to be infected with HCV, 59 (17.2%) completed the treatment plan, and 284 (82.8%) were monitored and referred to the treatment system. Throughout the development of this model, all stakeholders and relevant networks participated in each stage, ensuring continuous evaluation, improvement, and adaptation to suit the local context. The system encompasses HCV prevention and control for inmates, spanning from intake to release and subsequent reintegration into the community. It is expected that this model can serve as a valuable framework for application in other prisons settings.

Downloads

Download data is not yet available.

References

World Health Organization. Hepatitis C [Internet]. Geneva: World Health Organization 2021 [cited 2021 Nov 11]. Available from: https://www.who.int/news-room/fact-sheets/detail/hepatitis-c

Strategy and Planning Division of Office of the Permanent Secretary Ministry of Public Health. Public health statistics A.D. 2021. Bangkok: Strategy and Planning Division of Office of the Permanent Secretary Ministry of Public Health; 2021. (in Thai)

Verachai V, Phutiprawan T, Theamboonlers A, Chinchai T, Tanprasert S, Haagmans BL, et al. Prevalence and genotypes of hepatitis C virus infection among drug addicts and blood donors in Thailand. Southeast Asian J Trop Med Public Health. 2002;33(4):849-51.

Division of AIDS and STIs, Department of Disease Control. Thailand practice guideline for eliminate hepatitis C. Bangkok: J. S. Printing Group; 2021. (in Thai)

Proungvitaya T, Jantorn S, Suwannathada S, Homchampa P, Proungvitaya S. Incidence of hepatitis B and C virus in new cases of hepatocellular carcinoma patients attending at National Cancer Institute. Arch AHS. 2012;24(3):264-71. (in Thai)

Belaunzaran-Zamudio PF, Mosqueda-Gomez JL, Macias-Hernandez A, Sierra-Madero JG, Ahmed S, Beyrer C. Risk factors for prevalent hepatitis C virus-infection among inmates in a state prison system in Mexico. PLoS ONE. 2017;12(6):e0179931.

Pimsing N, Wasitthankasem R, Treesun K, Poovorawan Y, Posuwan N. Prevalence and risk factors of hepatitis C virus in Phetchabun. Journal of Disease Prevention and Control: DPC. 2 Phitsanulok. 2021;8(3):28-40. (in Thai)

Tanwandee T, Piratvisuth T, Phornphutkul K, Mairiang P, Permpikul P, Poovorawan Y. Risk factors of hepatitis C virus infection in blood donors in Thailand: a multicenter case-control study. J Med Assoc Thail. 2006;89(Suppl 5):S79-83.

Jafari S, Copes R, Baharlou S, Etminan M, Buxton J. Tattooing and the risk of transmission of hepatitis C: a systematic review and meta-analysis. Int J Infect Dis. 2010;14(11):e928-40.

Kemmis S, McTaggart R. The action research planner. Australia: Deakin University Press; 1988.

Chayathab B. The development of caring pattern for tuberculosis pattern through participation of health volunteers in a Correctional Institution [master’s thesis]. Bangkok: Christian University of Thailand; 2014. 116 p. (in Thai)

Fiore V, De Matteis G, Pontali E, De Vito A, Panese S, Geremia N, et al. Quick diagnosis, staging, and treatment of HCV infection among people living in prison: opinion expert panel. Front Public Health. 2022;10:926414.

Downloads

Published

2023-12-30

How to Cite

1.
Surakan P, Leenwiphat N, Phutachai P, Uthruk K, Paladchai P. Results of the development of the hepatitis C prevention and control system in Kalasin Provincial Prison. Thai AIDS Journal [internet]. 2023 Dec. 30 [cited 2026 Jan. 1];35(3):140-5. available from: https://he02.tci-thaijo.org/index.php/ThaiAIDSJournal/article/view/265735

Issue

Section

Original Article